Skip to content

Expansion to Interdisciplinary HIV Prevention in Women

Preventing FAS/ARND in Russian Children/Expansion to Interdisciplinary HIV Prevention in Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01994603
Enrollment
41
Registered
2013-11-26
Start date
2012-12-31
Completion date
2015-09-30
Last updated
2016-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS, Alcohol Related Neurodevelopmental Disorder, Fetal Alcohol Syndrome, HIV

Keywords

Prevention, HIV, AIDS, Fetal Alcohol Syndrome (FAS), Alcohol Related Neurodevelopmental Disorder (ARND)

Brief summary

This trial will pilot test intervention strategies to increase utilization of HIV testing and gain knowledge for designing a clinical trial to evaluate prevention strategies to reduce HIV sexual transmission in the general population in Russia. The study will assess whether external (cost, convenience) or internal factors (low perception of own risk, reluctance to identify a partner as at-risk, fear of stigma) drive Russian women's reluctance to be tested and if peer support impacts their decision. A randomized experimental manipulation, comparing opt-in vs. bundled opt-out testing approaches, followed by focus group discussions, followed by a second-chance testing offer will be used to inform these questions. The answers will enable the international research team to engineer and then test an HIV testing promotion strategy in Russia. The project will collect preliminary data for a larger study to develop an evidence-based program to reduce the HIV transmission in this high risk population.

Detailed description

A mixed methods research design combining qualitative and quantitative data collection methods will be used to increase the understanding of barriers to HIV testing, identify promising strategies to increase testing, generate research hypotheses, and design a future randomized clinical trial to evaluate HIV prevention targeted to at-risk women in the general population in Russia. The qualitative methods include structured interviews and a focus group participation to assess women's reasons for being the tested and possible prevention strategies. The quantitative methods include observation/recording of women's testing behaviors.

Interventions

Study participants will be offered a health screening onsite.

BEHAVIORALFocus Group

Study participants will be invited to participate in a focus group discussion.

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

* A parent study participants who completed HIV risk survey and * Reported two or more partners in the last 12 months and no or inconsistent condom use in the last 3 months and no HIV testing in the last 12 months * Or reported any sexually-transmitted disease and no HIV testing in the last 12 months

Exclusion criteria

* A parent study participants who declined to be contacted for participating in future research studies

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who completed HIV testFirst 1: at initial contact, an expected average of 15 minutesA brief survey completed over the phone. Participants asked when the last HIV test was completed and her reasons for taking the test.
Number of participants who accepted a rapid health screening/HIV testPhase 2: an expected average of 2 hoursWomen's decision to take/not take a health screening test/HIV test is recorded. If a woman chooses to be tested, she will be asked a few questions to assess her reasons for being tested. She will be provided with the results of the testing. If a woman's test is positive for HIV (or other health risks in the bundled opt-out condition), counseling with a trained study nurse, physician or psychologist will be available on-site and a referral for additional testing, counseling, and appropriate medical care will be provided.

Secondary

MeasureTime frameDescription
Brief survey to assess reasons for being testedPhase 2: at time of completing HIV testingParticipants who accepted a rapid health screening/HIV test are asked about reasons for taking the test at this time

Countries

Russia, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026